Search Results 111-120 of 16028 for melatonin receptor agonists

  1. Transplant endocrinology at Mayo Clinic

    "We have found use of GLP-1 receptor agonists and SGLT2 inhibitors to be safe in the majority of these patients based on retrospective analysis, with ...

  2. Evaluation of the Effects of Caffeine, Via the ACE2 Receptor, on Clinical Severity of COVID-19 Disease

    The purpose of this study is to assess levels of caffeine intake among patients who tested positive for COVID-19 infection and compare that to disease severity.

  3. A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer - Mayo Clinic

    A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer · Share · Facebook ...

  4. DAYBREAK: Phase 2 Study in Patients With Specific Gene Defects in the MC4R Pathway - Mayo Clinic

    ... receptor (MC4R) pathway who achieve a clinically meaningful reduction in ... Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to ...

  5. Publications - Search Publications by Mayo Clinic Authors - Mayo Clinic Research

    Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with ...

  6. Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis - Mayo Clinic

    The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...

  7. A Study of the Effect of Liraglutide on Weight Loss and Stomach Functions in Obesity - Mayo Clinic

    ... agonists for hypertension, or other GLP-1 receptor agonists (exenatide) or amylin analogs (pramlintide) are not permissible because they significantly ...

  8. A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea - Mayo Clinic

    Studies show that sleep apnea increases the risk of cardiovascular disease and is associated with obesity. However, it is unclear how sleep apnea affects fat ...

  9. Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma - Mayo Clinic News Network

    "CAR-T cell therapy is a promising treatment for non-Hodgkin lymphoma, especially for patients who have relapsed or those who have not responded to prior ...

  10. Incidence and characteristics of therapy-related myeloid neoplasms after peptide receptor radionuclide therapy in patients with neuroendocrine tumors - Mayo Clinic

    Lutetium Lu 177 dotatate, a peptide receptor radionuclide therapy (PRRT), is a tumor-targeted treatment that uses radiation to induce tumor cell death in ...